Logo BizupsLogo Bizups
    • Investors
    • Accelerators
    • Incubators
    • Startups

      Ontario

      • Home
      • Province
      • Ontario
      • Ontario Innovation News
      Iris&Romeo Strikes First Retail Partnership With Credo Beauty [Beauty Independent]
      • Nov. 18, 2024, 12:19 a.m.

      Iris&Romeo Strikes First Retail Partnership With Credo Beauty [Beauty Independent]

      Awake close CAD 5 million funding round with BTV [BTomorrow Ventures]
      • Nov. 18, 2024, 12:19 a.m.

      Awake close CAD 5 million funding round with BTV [BTomorrow …

      Acid League is swinging for the fences [The New Consumer]
      • Nov. 18, 2024, 12:19 a.m.

      Acid League is swinging for the fences [The New Consumer]

      Purpose Report 2023
      • Nov. 17, 2024, 11:36 p.m.

      Purpose Report 2023

      Why Georgian Invested in Armis (Again)
      • Nov. 17, 2024, 11:36 p.m.

      Why Georgian Invested in Armis (Again)

      Why Georgian Invested in Glooko (Again)
      • Nov. 17, 2024, 11:36 p.m.

      Why Georgian Invested in Glooko (Again)

      Why Georgian Invested in You.com
      • Nov. 17, 2024, 11:36 p.m.

      Why Georgian Invested in You.com

      Why Georgian Invested in Coder
      • Nov. 17, 2024, 11:36 p.m.

      Why Georgian Invested in Coder

      Why Georgian is Investing in SurrealDB
      • Nov. 17, 2024, 11:36 p.m.

      Why Georgian is Investing in SurrealDB

      Redefining Legal Impact with the Team at Darrow
      • Nov. 17, 2024, 11:36 p.m.

      Redefining Legal Impact with the Team at Darrow

      Testing LLMs for Trust and Safety
      • Nov. 17, 2024, 11:36 p.m.

      Testing LLMs for Trust and Safety

      Introducing Georgian’s “Crawl, Walk, Run” Framework for Adopting Generative AI
      • Nov. 17, 2024, 11:36 p.m.

      Introducing Georgian’s “Crawl, Walk, Run” Framework for Adopting Generative AI

      How AI is Redefining Coding
      • Nov. 17, 2024, 11:36 p.m.

      How AI is Redefining Coding

      Thryv Therapeutics Completes Phase 1 Dosing of its Second Novel SGK1 Inhibitor THRV-1268 – Future Studies in Heart Failure and Atrial Fibrillation to Commence in 2025
      • Nov. 15, 2024, 8:46 p.m.

      Thryv Therapeutics Completes Phase 1 Dosing of its Second Novel …

        • 16
        • 17
        • 18
        • 19
        • 20
        • 21
        • 22
        • 23
        • 24

      Search Posts

      Logo Bizups

      Uncover the Startup Ecosystem

      • [email protected]

      Links

      • Investors
      • Accelerators
      • Incubators
      • Startups

      Links

      • Programs
      • Events
      • Mentors
      • Posts
      • Live

      Support

      • About Us
      • User Guide
      • Disclaimer
      • Privacy Policy
      • Contact Us

      Social Media

      © Bizups.info. All rights reserved.
      Login
      Sign In/Sign Up with linkedin
      Signup

      Your signup was successful. To complete the process of registering your first name, please refer to your email and confirm the email received from us.

      We found a number of people with your first name. When you find your first name in this list, select it

      This section is for the registration of real people's first name, it will be canceled in case of registration with name/organization or startup profile. After registering First name, you can add and manage your startup.Entering all requested information is mandatory